SCHEMBL1237101

SCHEMBL1237101

CCCCCCNC(CC)CC

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 8/20 0.48
TSHR P16473 2/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 2/20 0.44
KDM4E B2RXH2 2/20 0.44
CNR1 P21554 1/20 0.44
ADRA1A P35348 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ABCC3 O15438 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
ADH1B P00325 1/20 0.42
ADH1C P00326 1/20 0.42
ADH1A P07327 1/20 0.42
ADH4 P08319 1/20 0.42
ADH7 P40394 1/20 0.42
THRB P10828 1/20 0.42
PPARA Q07869 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7776968 1.00 EPHX1 (0.48) EPHX1TSHRALDH1A1LMNAKDM4E
SCHEMBL20033727 1.00 EPHX1 (0.48) EPHX1TSHRALDH1A1LMNAKDM4E
SCHEMBL10879682 1.00 EPHX1 (0.48) EPHX1TSHRALDH1A1LMNAKDM4E
SCHEMBL10393993 1.00 EPHX1 (0.48) EPHX1TSHRALDH1A1LMNAKDM4E
SCHEMBL27599073 1.00 EPHX1 (0.48) EPHX1TSHRALDH1A1LMNAKDM4E
SCHEMBL25132260 1.00 EPHX1 (0.48) EPHX1TSHRALDH1A1LMNAKDM4E
Hydrochloric Acid SCHEMBL27579875 0.97 ABCC3 (0.46) EPHX1TSHRALDH1A1LMNAKDM4E
Bromide SCHEMBL10874058 0.97 EPHX1 (0.46) EPHX1TSHRALDH1A1LMNAKDM4E
Ammonia Solution, Strong SCHEMBL197373 0.97 EPHX1 (0.46) EPHX1TSHRALDH1A1LMNAKDM4E
Hydrochloric Acid SCHEMBL1526262 0.97 ABCC3 (0.46) EPHX1TSHRALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11771715-B2 Circular RNA compositions and methods ORNA THERAPEUTICS, INC. (US) 2023-10-03 US disclosed
US-11766449-B2 Circular RNA compositions and methods ORNA THERAPEUTICS, INC. (US) 2023-09-26 US disclosed
US-20230226096-A1 CIRCULAR RNA COMPOSITIONS AND METHODS ORNA THERAPEUTICS, INC. 2023-07-20 US disclosed
US-11679120-B2 Circular RNA compositions and methods ORNA THERAPEUTICS, INC. (US) 2023-06-20 US disclosed
EP-3078962-B1 LIQUID MEDIUM FOR PREVENTING CHARGE-UP IN ELECTRON MICROSCOPE AND METHOD OF OBSERVING SAMPLE USING THE SAME HITACHI HIGH TECH CORP (JP) 2018-06-27 EP disclosed
CN-107405617-A Anion exchange membrane, electrochemical element and electrochemical device having the same 日东电工株式会社 2017-11-28 CN disclosed
CN-107406534-A Ionomer resin, ionomer solution containing the ionomer resin, laminate, member, electrochemical element, and electrochemical device 日东电工株式会社 2017-11-28 CN disclosed
EP-3078962-A1 LIQUID MEDIUM FOR PREVENTING CHARGE-UP IN ELECTRON MICROSCOPE AND METHOD OF OBSERVING SAMPLE USING THE SAME Hitachi High-Technologies Corporation (JP) 2016-10-12 EP disclosed
EP-1978355-B1 METHOD OF OBSERVING SAMPLE USING A LIQUID MEDIUM FOR PREVENTING CHARGE-UP IN AN ELECTRON MICROSCOPE HITACHI HIGH TECH CORP (JP) 2016-07-27 EP disclosed
EP-1699761-B1 CB1 MODULATOR COMPOUNDS LILLY CO ELI (US) 2011-03-16 EP disclosed
US-7880144-B2 Liquid medium for preventing charge-up in electron microscope and method of observing sample using the same Juridical Foundation Osaka Industrial Promotion Organization c/o Mydome Osaka (JP) 2011-02-01 US disclosed
US-20090173882-A1 Liquid Medium For Preventing Charge-Up in Electron Microscope and Method of Observing Sample Using The Same HITACHI HIGH-TECH CORPORATION (JP) 2009-07-09 US disclosed
EP-1978355-A1 LIQUID MEDIUM FOR PREVENTING CHARGE-UP IN ELECTRON MICROSCOPE AND METHOD OF OBSERVING SAMPLE USING THE SAME Juridical Foundation Osaka Industrial Promotion Organization (JP) 2008-10-08 EP disclosed
CN-1207363-C Antistatic agent BAYER AG (DE) 2005-06-22 CN disclosed
CN-1429260-A Antistatic agent BAYER AG (DE) 2003-07-09 CN disclosed
EP-0838508-B1 Aqueous ink composition for use in an ink-jet printer SEIKO EPSON CORP (JP) 2001-08-29 EP disclosed
US-5871572-A COLORANT, WATER, A WATER-SOLUBLE ORGANIC SOLVENT, AND PECTIC ACID SEIKO EPSON CORPORATION (JP) 1999-02-16 US disclosed
EP-0838508-A2 Aqueous ink composition for use in an ink-jet printer SEIKO EPSON CORPORATION (JP) 1998-04-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11771715-B2 Circular RNA compositions and methods RTCB, HNRNPA1, HNRNPAB EPHX1 4437/4885TSHR 1491/4885ALDH1A1 4484/4885
US-20230226096-A1 CIRCULAR RNA COMPOSITIONS AND METHODS RTCB, HNRNPA1, HNRNPAB EPHX1 4437/4885TSHR 1491/4885ALDH1A1 4484/4885
US-11679120-B2 Circular RNA compositions and methods RTCB, HNRNPA1, HNRNPAB EPHX1 4437/4885TSHR 1491/4885ALDH1A1 4484/4885
US-11766449-B2 Circular RNA compositions and methods RTCB, RNGTT, HNRNPAB EPHX1 4605/4885TSHR 1390/4885ALDH1A1 4532/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.